Logos Global Management LP Travere Therapeutics, Inc. Transaction History

Logos Global Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$23.61 - $30.6 $2.36 Million - $3.06 Million	-100,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$24.34 - $31.17 $2.43 Million - $3.12 Million	100,000 New	100,000 $3.1 Million
Q1 2021 May 17, 2021	SELL	$23.37 - $31.77 $1.43 Million - $1.94 Million	-61,152 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$19.17 - $27.87 $1.17 Million - $1.7 Million	61,152 New	61,152 $1.67 Million

187

89.5M

137K

184K

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.27B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.